Cited by 155T-cell and B-cell ImmunologyTGF-β signaling in diseasesCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo

Open access

Cuende, Julia, Liénart, Stéphanie, Dedobbeleer, Olivier, van der Woning, Bas, De Boeck, Gitte, Stockis, Julie, Huygens, Caroline, Colau, Didier, Somja, Joan, Delvenne, Philippe, Hannon, Muriel, Baron, Frédéric, Dumoutier, Laure, Renauld, Jean-Christophe, De Haard, Hans, Saunders, Michael, Coulie, Pierre G., Lucas, Sophie·2015·Science Translational Medicine

DOI 10.1126/scitranslmed.aaa1983

Open this paper in CoChat — free account

Abstract

Monoclonal antibodies that inhibit human T reg function in vivo may be used therapeutically in cancer or infections.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaa1983

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

1 retracted

Regulatory T Cells in the Human Immune System
Kim, Y. M. (2010) · Korean Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.3342/kjorl-hns.2010.53.12.737 · Cited by 12
Retracted
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230
TGFβ in Cancer
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Regulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2785 · Cited by 2,524
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,264
Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β
Nakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,596
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.
Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S. B., Álvarez‐Mon, M., Derynck, R., Sporn, M. B., & Fauci, A. S. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.5.1037 · Cited by 1,581
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Simpson, T. R., Li, F., Montalvo-Ortiz, W., Sepulveda, M. A., Bergerhoff, K., Arce, F., Roddie, C., Henry, J. Y., Yagita, H., Wolchok, J. D., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130579 · Cited by 1,472
Epigenetic Control of the foxp3 Locus in Regulatory T Cells
Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J. K., Schlawe, K., Chang, H., Bopp, T., Schmitt, E., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050038 · Cited by 1,296
Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate
Zheng, Y., Josefowicz, S. Z., Chaudhry, A., Peng, X. P., Forbush, K. A., & Rudensky, A. Y. (2010) · Nature · doi:10.1038/nature08750 · Cited by 1,170
Humanized mice for immune system investigation: progress, promise and challenges
Shultz, L. D., Brehm, M. A., García, J. V., & Greiner, D. L. (2012) · Nature reviews. Immunology · doi:10.1038/nri3311 · Cited by 1,018
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells
Selby, M. J., Engelhardt, J. J., Quigley, M., Henning, K. A., Chen, T., Srinivasan, M., & Korman, A. J. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0013 · Cited by 857
TGF-β Activation and Function in Immunity
Travis, M. A., & Sheppard, D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120257 · Cited by 856
Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent Mechanisms
Li, M. O., Sanjabi, S., & Flavell, R. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.011 · Cited by 794
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation
Li, M. O., Wan, Y. Y., & Flavell, R. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.014 · Cited by 769
Foxp3 in control of the regulatory T cell lineage
Zheng, Y., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1455 · Cited by 707
DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells
Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grützkau, A., Dong, J., Thiel, A., Boeld, T. J., Hoffmann, P., Edinger, M., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737594 · Cited by 701
TGF-β1 Plays an Important Role in the Mechanism of CD4+CD25+ Regulatory T Cell Activity in Both Humans and Mice
Nakamura, K., Kitani, A., Fuss, I. J., Pedersen, A., Harada, N., Nawata, H., & Strober, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.834 · Cited by 630
CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and Responsiveness
Piccirillo, C. A., Letterio, J. J., Thornton, A. M., McHugh, R. S., Mamura, M., Mizuhara, H., & Shevach, E. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020590 · Cited by 589
A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells
Liu, Y., Zhang, P., Li, J., Kulkarni, A. B., Perruche, S., & Chen, W. (2008) · Nature Immunology · doi:10.1038/ni.1607 · Cited by 547
Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.
Tao, M., & Morrison, S. L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2595 · Cited by 531
Immune Modulation in Cancer with Antibodies
Page, D. B., Postow, M. A., Callahan, M. K., Allison, J. P., & Wolchok, J. D. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-092012-112807 · Cited by 523
T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells
Fahlén, L., Read, S., Gorelik, L., Hurst, S. D., Coffman, R. L., Flavell, R. A., & Powrie, F. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040685 · Cited by 516
Phase I study of GC1008 (fresolimumab): a human anti‐transforming growth factor‐beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma
Morris, J. C., Tan, A. R., Olencki, T. E., Shapiro, G. I., Dezube, B. J., Reiss, M., Hsu, F. J., Berzofsky, J. A., & Lawrence, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090353 · Cited by 487
Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice with the T Cell-Specific Targeting of Transforming Growth Factor-β Receptor
Marie, J. C., Liggitt, D., & Rudensky, A. Y. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.012 · Cited by 480
GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3 + regulatory T cells
Tran, D. Q., Andersson, J., Wang, R., Ramsey, H. E., Unutmaz, D., & Shevach, E. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901944106 · Cited by 473
Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue
Wieczorek, G., Asemissen, A. M., Model, F., Türbachova, I., Floess, S., Liebenberg, V., Baron, U., Stauch, D., Kotsch, K., Pratschke, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2361 · Cited by 321
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
Jacobs, J. F. M., Nierkens, S., Figdor, C. G., de Vries, I. J. M., & Adema, G. J. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70155-3 · Cited by 254
Membrane protein GARP is a receptor for latent TGF‐β on the surface of activated human Treg
Stockis, J., Colau, D., Coulie, P. G., & Lucas, S. (2009) · European Journal of Immunology · doi:10.1002/eji.200939684 · Cited by 252
Self-citation
Crosstalk between Human IgG Isotypes and Murine Effector Cells
Overdijk, M. B., Verploegen, S. A. B. W., Buijsse, A. O., Vink, T., Leusen, J. H. W., Bleeker, W. K., & Parren, P. W. H. I. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200356 · Cited by 232
TREG-cell therapies for autoimmune rheumatic diseases
Miyara, M., Ito, Y., & Sakaguchi, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.105 · Cited by 218
GARP regulates the bioavailability and activation of TGFβ
Wang, R., Zhu, J., Dong, X., Shi, M., Lu, C., & Springer, T. A. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-12-1018 · Cited by 188
Identification of a Regulatory T Cell Specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression
Wang, R., Wan, Q., Kozhaya, L., Fujii, H., & Unutmaz, D. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002705 · Cited by 171
Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins
Macaulay, I. C., Tijssen, M. R., Thijssen‐Timmer, D. C., Gusnanto, A., Steward, M., Burns, P., Langford, C. F., Ellis, P. D., Dudbridge, F., Zwaginga, J. J., et al. (2006) · Blood · doi:10.1182/blood-2006-07-036269 · Cited by 171
Selection of highly transfectable variant from mouse mastocytoma P815
Pel, A. V., Plaen, E. D., & Boon, T. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534840 · Cited by 131
GARP: a key receptor controlling FOXP3 in human regulatory T cells
Probst‐Kepper, M., Geffers, R., Kröger, A., Viegas, N., Erck, C., Hecht, H., Lünsdorf, H., Roubin, R., Moharregh-Khiabani, D., Wagner, K., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00782.x · Cited by 123
Enhancement of IgG anti‐carrier responses by IgG2 anti‐hapten antibodies in mice
Coulie, P. G., & Snick, J. V. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150810 · Cited by 108
Self-citation
Release of Active TGF-β1 from the Latent TGF-β1/GARP Complex on T Regulatory Cells Is Mediated by Integrin β8
Edwards, J. P., Thornton, A. M., & Shevach, E. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401102 · Cited by 106
Regulation of the Expression of GARP/Latent TGF-β1 Complexes on Mouse T Cells and Their Role in Regulatory T Cell and Th17 Differentiation
Edwards, J. P., Fujii, H., Zhou, A. X., Creemers, J. W. M., Unutmaz, D., & Shevach, E. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300199 · Cited by 94
Antibody Targeting of TGF-β in Cancer Patients
Lonning, S. M., Mannick, J. B., & McPherson, J. M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798808392 · Cited by 84
Targeting regulatory T cells
Ménétrier‐Caux, C., Curiel, T. J., Faget, J., Manuel, M., Caux, C., & Zou, W. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0208-y · Cited by 79
Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents
de Vries, I. J. M., Castelli, C., Huygens, C., Jacobs, J. F. M., Stockis, J., Schuler‐Thurner, B., Adema, G. J., Punt, C. J. A., Rivoltini, L., Schuler, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2227 · Cited by 78
Self-citation
Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins
O'Connor, M. N., Salles, I. I., Cvejic, A., Watkins, N. A., Walker, A. R., Garner, S. F., Jones, C. I., Macaulay, I. C., Steward, M., Zwaginga, J. J., et al. (2008) · Blood · doi:10.1182/blood-2008-06-162693 · Cited by 77
Comparison of stable human Treg and Th clones by transcriptional profiling
Stockis, J., Fink, W., François, V., Connerotte, T., Smet, C. D., Knoops, L., van der Bruggen, P., Boon, T., Coulie, P. G., & Lucas, S. (2009) · European Journal of Immunology · doi:10.1002/eji.200838807 · Cited by 72
Self-citation
Infusion of clinical‐grade enriched regulatory T cells delays experimental xenogeneic graft‐versus‐host disease
Hannon, M., Lechanteur, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., Baudoux, É., Giet, O., Chantillon, A., et al. (2013) · Transfusion · doi:10.1111/trf.12279 · Cited by 62
Self-citation
Application of Monoclonal Antibodies in Functional and Comparative Investigations of Heavy-Chain Immunoglobulins in New World Camelids
Daley, L. P., Gagliardo, L. F., Duffy, M. S., Smith, M. C., & Appleton, J. A. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.3.380-386.2005 · Cited by 58
Four individually druggable MET hotspots mediate HGF-driven tumor progression
Basilico, C., Hultberg, A., Blanchetot, C., Jonge, N. D., Festjens, E., Hanssens, V., Osepa, S.-I., Boeck, G. D., Mira, A., Cazzanti, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72316 · Cited by 54
Self-citation
GARP Is Regulated by miRNAs and Controls Latent TGF-β1 Production by Human Regulatory T Cells
Gauthy, E., Cuende, J., Stockis, J., Huygens, C., Lethé, B., Collet, J., Bommer, G. T., Coulie, P. G., & Lucas, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076186 · Cited by 41
Self-citation
Structure and developmental expression of mouse Garp, a gene encoding a new leucine-rich repeat-containing protein
Roubin, R., Pizette, S., Ollendorff, V., Planche, J., Birnbaum, D., & deLapeyrière, O. (1996) · The International Journal of Developmental Biology · doi:10.1387/ijdb.8840187 · Cited by 33
Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 inL. majorinfection
Uyttenhove, C., Marillier, R. G., Tacchini‐Cottier, F., Charmoy, M., Caspi, R. R., Damsker, J. M., Goriely, S., Su, D., Damme, J. V., Struyf, S., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1210699 · Cited by 29
Induction of autoantibodies against mouse soluble proteins after immunization with living cells presenting the autoantigen at the cell surface in fusion with a human type 2 transmembrane protein
Lemaire, M. M., Vanhaudenarde, A., Nizet, Y., Dumoutier, L., & Renauld, J. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.02.001 · Cited by 14
Self-citation
Complementation of non-tumorigenicity of HPV18-positive cervical carcinoma cells involves differential mRNA expression of cellular genes including potential tumor suppressor genes on chromosome 11q13
Kehrmann, A., Truong, H., Repenning, A., Boger, R. J., Klein‐Hitpaß, L., Pascheberg, U., Beckmann, A., Opalka, B., & Kleine‐Lowinski, K. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.06.002 · Cited by 10

Research works printed but not linked: 1

10.1016/0003-2697(87)90021-2 · DOI

Sorted by citations

Transforming Growth Factor-β Signaling in Immunity and Cancer
Batlle, E., & Massagué, J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.024 · Cited by 2,366
Targeting TGF-β signal transduction for fibrosis and cancer therapy
Peng, D., Fu, M., Wang, M., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01569-x · Cited by 1,151
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
TGF-β1 – A truly transforming growth factor in fibrosis and immunity
Lodyga, M., & Hinz, B. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.12.010 · Cited by 467
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403

See all 155

Authors: Cuende, J., Liénart, S., Dedobbeleer, O., van der Woning, B., De Boeck, G., Stockis, J., Huygens, C., Colau, D., Somja, J., Delvenne, P., Hannon, M., Baron, F., Dumoutier, L., Renauld, J.-C., De Haard, H., Saunders, M., Coulie, P. G., & Lucas, S.
Affiliations: de Duve Institute (BE)
arGEN-X BVBA, Technologiepark 30, B9052 Zwijnaarde, Gent, Belgium.
Ludwig Cancer Research (BE)
University of Liège (BE)
Argenx (Belgium) (BE)
Corresponding author: Cuende, Julia
Liénart, Stéphanie
Lucas, Sophie
ORCID: Liénart, Stéphanie
Stockis, Julie
Colau, Didier
Somja, Joan
Delvenne, Philippe
Baron, Frédéric
Dumoutier, Laure
Renauld, Jean-Christophe
Coulie, Pierre G.
Lucas, Sophie
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2015-04-22
Volume: 7
Issue: 284
Pages: 284ra56-284ra56
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.aaa1983
OpenAlex: W2113024959
Cited by: 155
References: 59
Citations by year: 2026: 6 · 2025: 8 · 2024: 17 · 2023: 13 · 2022: 16 · 2021: 20 · 2020: 17 · 2019: 15 · 2018: 14 · 2017: 12 · 2016: 12 · 2015: 5
FWCI: 7.04
Type: journal article
Language: en
Open access: green
orbi.uliege.be
Licence: other-oa
www.sciencemag.org/about/science-licenses-journal-article-reuse (vor, 366 d)
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
ORBi (University of Liège) (submittedVersion, other-oa)
Funders: Fondation contre le Cancer (Belgium)
Fonds J. Maisin (Belgium)
Fonds National pour la Recherche Scientifique
Belgian Cancer Plan (Action 29_024)
Fonds National pour la Recherche Scientifique (Belgium)
Fondation Salus Sanguinis (Belgium)
Actions de Recherche Concertees (ARC 09/14-021)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: regulatory T cells, GARP, TGF-β1, monoclonal antibodies, TGF-β1 activation, immunosuppression, graft-versus-host disease, cancer immunotherapy, conformational epitopes, cancer vaccines, CTLA-4, PD-1/PD-L1
MeSH terms: Animals, Antibodies, Monoclonal, Epitopes, Graft vs Host Disease, Humans, Immunosuppressive Agents, Membrane Proteins, Methylation, Mice, Inbred BALB C, Mice, Transgenic, Protein Binding, Protein Conformation, Autoimmunity, Mice, SCID, Mice, Inbred NOD, T-Lymphocytes, Regulatory, Mice, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks